Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
82,773,190
-
Total 13F shares
-
51,686,909
-
Share change
-
+157,471
-
Total reported value
-
$2,124,275,170
-
Put/Call ratio
-
220%
-
Price per share
-
$41.08
-
Number of holders
-
307
-
Value change
-
-$9,901,736
-
Number of buys
-
139
-
Number of sells
-
143
Institutional Holders of Editas Medicine, Inc. - Common Stock (EDIT) as of Q3 2021
As of 30 Sep 2021,
Editas Medicine, Inc. - Common Stock (EDIT) was held by
307 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
51,686,909 shares.
The largest 10 holders included
VANGUARD GROUP INC, ARK Investment Management LLC, BlackRock Inc., Sumitomo Mitsui Trust Holdings, Inc., Nikko Asset Management Americas, Inc., STATE STREET CORP, GOLDMAN SACHS GROUP INC, Capital World Investors, GEODE CAPITAL MANAGEMENT, LLC, and JPMORGAN CHASE & CO.
This page lists
307
institutional shareholders reporting positions in this security
for the Q3 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.